Tetherin and its viral antagonists.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

1. Elevated proportion of BST2 + CD4 + T cells: a potential biomarker for diagnosis and disease activity in Sjögren's disease.Clinical rheumatology · 2026
   Article
2. Polypeptides inhibit HIV-1 replication by interfering viral Vpu-mediated tetherin degradation.Infectious medicine · 2023
   Article
3. The RING finger protein family in health and disease.Signal transduction and targeted therapy · 2022
   Review
4. Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions.Intervirology · 2022
   Review
5. Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.Viruses · 2020
   Review
6. Microbial Biofilms: Human T-cell Leukemia Virus Type 1 First in Line for Viral Biofilm but Far Behind Bacterial Biofilms.Frontiers in microbiology · 2020
   Review
7. The viral protein corona directs viral pathogenesis and amyloid aggregation.Nature communications · 2019
   Article
8. Host and Viral Proteins Modulating Ebola and Marburg Virus Egress.Viruses · 2019
   Review
9. Herpes Simplex Virus Evasion of Early Host Antiviral Responses.Frontiers in cellular and infection microbiology · 2019
   Review
10. HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation.Innate immunity · 2018
    Article
11. BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection.PLoS pathogens · 2018
    Article
12. IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.Frontiers in immunology · 2017
    Article
13. Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages.Scientific reports · 2016
    Article
14. MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction.International journal of molecular sciences · 2016
    Article
15. Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.Frontiers in immunology · 2013
    Review
16. Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.Viruses · 2013
    Review
17. Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Viruses · 2013
    Review
18. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.Frontiers in microbiology · 2013
    Article
19. Virus morphogenesis in the cell: methods and observations.Sub-cellular biochemistry · 2013
    Review
20. Molecular mechanism of arenavirus assembly and budding.Viruses · 2012
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as